Medtronic (MDT) Net Equity Issued and Repurchased (2014 - 2026)

Medtronic has disclosed Net Equity Issued and Repurchased across 13 years of filings, most recently posting $20.0 million for Q3 2026.

• In Q3 2026, Net Equity Issued and Repurchased fell 78.95% year-over-year to $20.0 million; the TTM figure through Jul 2026 stood at $441.0 million (down 14.2% YoY), while the FY2026 annual figure was $516.0 million, up 1.57% from the prior year.
• Net Equity Issued and Repurchased came in at $20.0 million for Q3 2026 at Medtronic, down from $97.0 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $168.0 million in Q1 2025 to a low of $20.0 million in Q3 2026.
• Average Net Equity Issued and Repurchased over 5 years is $94.3 million, with a median of $89.0 million recorded in 2024.
• Year-over-year, Net Equity Issued and Repurchased surged 194.74% in 2025 and tumbled 78.95% in 2026.
• Over 5 years, Net Equity Issued and Repurchased stood at $110.0 million in 2022, then plunged by 34.55% to $72.0 million in 2023, then soared by 98.61% to $143.0 million in 2024, then rose by 11.89% to $160.0 million in 2025, then sank by 87.5% to $20.0 million in 2026.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $20.0 million in Q3 2026, $97.0 million in Q2 2026, and $164.0 million in Q1 2026.